Recombinant human G-CSF dimer and use thereof for the treatment of neurological diseases
This invention relates to a recombinant human G-CSF (rhG-CSF) dimer and its use in the treatment of neurological disorder. In particular, upon ischemic neural injury in animal, this invention can be used to protect neurons with the use of rhG-CSF dimer such that function of injured nerves can be res...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
01.03.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This invention relates to a recombinant human G-CSF (rhG-CSF) dimer and its use in the treatment of neurological disorder. In particular, upon ischemic neural injury in animal, this invention can be used to protect neurons with the use of rhG-CSF dimer such that function of injured nerves can be restored. Serum half-life of G-CSF dimer of this invention is prolonged and the biological activity thereof is increased. |
---|---|
AbstractList | This invention relates to a recombinant human G-CSF (rhG-CSF) dimer and its use in the treatment of neurological disorder. In particular, upon ischemic neural injury in animal, this invention can be used to protect neurons with the use of rhG-CSF dimer such that function of injured nerves can be restored. Serum half-life of G-CSF dimer of this invention is prolonged and the biological activity thereof is increased. |
Author | HUANG ZHIHUA HUANG YULIANG YANG HONGZHOU YAN XIAOQIANG SUN BILL N. C |
Author_xml | – fullname: HUANG YULIANG – fullname: YAN XIAOQIANG – fullname: YANG HONGZHOU – fullname: SUN BILL N. C – fullname: HUANG ZHIHUA |
BookMark | eNqNi0sOgkAQBWehC3936AuQKCzUrUR0LZq4I-3wEBKmm8wM9xcTD-CqXiqvlmYmKliY5w1W3asTlkjt6FjokuRlQXXn4ImlpjGAYgsPbahR_90UPTg6TM0kBaPXXt-d5X7qAjggrM284T5g8-PKUHG-59cEg1YIA1sIYvUoj-k-220PpzT74_IB-nE7Kg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US9273108B2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US9273108B23 |
IEDL.DBID | EVB |
IngestDate | Fri Sep 20 10:07:58 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US9273108B23 |
Notes | Application Number: US201314014413 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160301&DB=EPODOC&CC=US&NR=9273108B2 |
ParticipantIDs | epo_espacenet_US9273108B2 |
PublicationCentury | 2000 |
PublicationDate | 20160301 |
PublicationDateYYYYMMDD | 2016-03-01 |
PublicationDate_xml | – month: 03 year: 2016 text: 20160301 day: 01 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | GENERON (SHANGHAI) CORPORATION LTD |
RelatedCompanies_xml | – name: GENERON (SHANGHAI) CORPORATION LTD |
Score | 3.022251 |
Snippet | This invention relates to a recombinant human G-CSF (rhG-CSF) dimer and its use in the treatment of neurological disorder. In particular, upon ischemic neural... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | Recombinant human G-CSF dimer and use thereof for the treatment of neurological diseases |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160301&DB=EPODOC&locale=&CC=US&NR=9273108B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IPktmje5hCEJI1F6APTSG4lm2whhyalSfHvO7um0YvehllYdge-eezMzgA8aLbKeK5n1NIzkxoIJ8ocllMt5QbXHTNdcREoTqbWODbeEjPpQbH_CyP7hH7K5oiIqAzx3kh9vfl5xApkbWX9yApkVS_hwg2UNjoWM5MxNg48dzSfBTNf8X03jpTpu-ugmVafnj3U1gfoRdsCDKMPT3xK2fy2KOEpHM5xs7I5gx4vB3Ds7wevDeBo0ua7kWyhV59DIgLFNZOFK0RO1iOv1I9CkhdrviVpmZNdzYnw53i1IuiLCpp0heQEmbJ5ZavsSJuaqS-AhKOFP6Z4xGUnjmUcdZfRL6FfViW_AqLmdmqmVmaLzFpmMqYh3HSEo5pmlsrYEIZ_bnP9z9oNnAi5fpdd3UK_2e74Hdrhht1LCX4BjJWODg |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOJNUSM-92C4NVpKWzk0Jn1ZlRZiwfTW7LZLwoFCaIl_39m1oBe9TWaTze4k3zx2ZmcA7nqmyniuZYqhZbrSRzgpbMBypUd5n2sDnc64CBTDyAim_ddETxow3_6FkX1CP2VzRERUhnivpL5e_TxiubK2srxnc2Qtn_yJ5Xbr6FjMTMbY2LUtbzxyR07Xcaxp3I3erQGaafXh0UZtvYcetinA4H3Y4lPK6rdF8Y9gf4ybFdUxNHjRhpazHbzWhoOwzncjWUOvPIFEBIoLJgtXiJysR54VJ_ZJPl_wNaFFTjYlJ8Kf48sZQV9U0GRXSE6QKZtX1sqO1KmZ8hSI702cQMEjpjtxpNN4dxntDJrFsuDnQNTcpDo1MlNk1jKdsR7CTUM4qjQzVMY60Plzm4t_1m6hFUzCYTp8id4u4VDI-LsE6wqa1XrDr9EmV-xGSvMLYqqRAQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Recombinant+human+G-CSF+dimer+and+use+thereof+for+the+treatment+of+neurological+diseases&rft.inventor=HUANG+YULIANG&rft.inventor=YAN+XIAOQIANG&rft.inventor=YANG+HONGZHOU&rft.inventor=SUN+BILL+N.+C&rft.inventor=HUANG+ZHIHUA&rft.date=2016-03-01&rft.externalDBID=B2&rft.externalDocID=US9273108B2 |